Pfizer’s dividend yield is 6.8%, outpacing S&P 500
Pfizer’s management is committed to maintaining the company’s dividend, which totaled $2.445 billion in the first quarter.
The company’s dividend yield of 6.8% is significantly higher than the S&P 500’s 1% yield.
Pfizer’s focus on maintaining the dividend is evident in its 2026 capital allocation priorities, which include growing the dividend.
The company’s ability to support the dividend is not based on earnings, but rather its cash flow statement, which reported a large dividend payment in the first quarter.